Protease Inhibitor - Advocacy Groups Charge Schering-Plough With Racial Discrimination For

Advocacy Groups Charge Schering-Plough With Racial Discrimination For
Medical News Today - Two advocacy groups last week said Schering-Plough is discriminating against black people by excluding them from the Phase II clinical trial of its new hepatitis C therapy, the Newark Star-Ledger reports. The trial includes 300 patients around the

Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
innovations report - Last fall Dr. Peter Sarnow and a team of Stanford University scientists reported that the hepatitis C virus needs a specific microRNA, named miR-122, in order to replicate in cultured liver cells. When the scientists inactivated the microRNA, the